Relmada Therapeutics Inc (RLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2015 | 06-2014 | 12-2013 | 06-2013 | 12-2012 | |
| Operating Expenses | 17,099 | 12,947 | 6,774 | 1,525 | 3,157 |
| Operating Income | -17,099 | -12,947 | -6,774 | -1,525 | -3,157 |
| Interest Expense | 0 | 436 | 220 | 0 | 28 |
| Other Income | -3,704 | -7,954 | -12,878 | 0 | -3,676 |
| Pre-tax Income | -20,804 | -21,336 | -19,872 | -1,525 | -6,860 |
| Net Income Continuous | -20,804 | -21,336 | -19,872 | -1,525 | -6,860 |
| Net Income | $-20,804 | $-21,336 | $-19,872 | $-19,872 | $-6,860 |
| EPS Basic Total Ops | -8.36 | -34.60 | -163.60 | N/A | -12.68 |
| EPS Basic Continuous Ops | -8.37 | -34.61 | -163.55 | N/A | -12.67 |
| EPS Diluted Total Ops | -8.36 | -34.60 | -163.60 | N/A | -12.68 |
| EPS Diluted Continuous Ops | -8.37 | -34.61 | -163.55 | N/A | -12.67 |
| EBITDA(a) | $-17,090 | $-12,538 | $-6,585 | $-1,525 | $-3,157 |